Hikma Ventures leads Series A financing for development of Winterlight Labs’ AI vocal technology to detect central nervous system disorders and track efficacy of treatments
Home » Hikma Ventures leads Series A financing for development of Winterlight Labs’ AI vocal technology to detect central nervous system disorders and track efficacy of treatments
Hikma Ventures leads Series A financing for development of Winterlight Labs’ AI vocal technology to detect central nervous system disorders and track efficacy of treatments2019-11-182019-11-20http://redpeppermergers.com/wp-content/uploads/rpm-white-red-1.pngRedPepper Mergershttp://redpeppermergers.com/wp-content/uploads/rpm-white-red-1.png200px200px
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.